Literature DB >> 15006376

Design and synthesis of indolo[2,3-a]quinolizin-7-one inhibitors of the ZipA-FtsZ interaction.

Lee D Jennings1, Ken W Foreman, Thomas S Rush, Desiree H H Tsao, Lidia Mosyak, Yuanhong Li, Mohani N Sukhdeo, Weidong Ding, Elizabeth G Dushin, Cynthia Hess Kenny, Soraya L Moghazeh, Peter J Petersen, Alexey V Ruzin, Margareta Tuckman, Alan G Sutherland.   

Abstract

The binding of FtsZ to ZipA is a potential target for antibacterial therapy. Based on a small molecule inhibitor of the ZipA-FtsZ interaction, a parallel synthesis of small molecules was initiated which targeted a key region of ZipA involved in FtsZ binding. The X-ray crystal structure of one of these molecules complexed with ZipA was solved. The structure revealed an unexpected binding mode, facilitated by desolvation of a loosely bound surface water.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15006376     DOI: 10.1016/j.bmcl.2004.01.028

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

Review 1.  Essential biological processes of an emerging pathogen: DNA replication, transcription, and cell division in Acinetobacter spp.

Authors:  Andrew Robinson; Anthony J Brzoska; Kylie M Turner; Ryan Withers; Elizabeth J Harry; Peter J Lewis; Nicholas E Dixon
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

2.  Structural conservation of druggable hot spots in protein-protein interfaces.

Authors:  Dima Kozakov; David R Hall; Gwo-Yu Chuang; Regina Cencic; Ryan Brenke; Laurie E Grove; Dmitri Beglov; Jerry Pelletier; Adrian Whitty; Sandor Vajda
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

Review 3.  Development of Protein-Protein Interaction Inhibitors for the Treatment of Infectious Diseases.

Authors:  Andrew F Voter; James L Keck
Journal:  Adv Protein Chem Struct Biol       Date:  2017-08-24       Impact factor: 3.507

4.  New Frontiers in Druggability.

Authors:  Dima Kozakov; David R Hall; Raeanne L Napoleon; Christine Yueh; Adrian Whitty; Sandor Vajda
Journal:  J Med Chem       Date:  2015-08-11       Impact factor: 7.446

5.  Targeting the Wolbachia cell division protein FtsZ as a new approach for antifilarial therapy.

Authors:  Zhiru Li; Amanda L Garner; Christian Gloeckner; Kim D Janda; Clotilde K Carlow
Journal:  PLoS Negl Trop Dis       Date:  2011-11-29

6.  ZipA binds to FtsZ with high affinity and enhances the stability of FtsZ protofilaments.

Authors:  Anuradha Kuchibhatla; Anusri Bhattacharya; Dulal Panda
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

Review 7.  Determinants of Bacterial Morphology: From Fundamentals to Possibilities for Antimicrobial Targeting.

Authors:  Muriel C F van Teeseling; Miguel A de Pedro; Felipe Cava
Journal:  Front Microbiol       Date:  2017-07-10       Impact factor: 5.640

Review 8.  A key bacterial cytoskeletal cell division protein FtsZ as a novel therapeutic antibacterial drug target.

Authors:  Mujeeb Ur Rahman; Ping Wang; Na Wang; Yaodong Chen
Journal:  Bosn J Basic Med Sci       Date:  2020-08-03       Impact factor: 3.363

9.  In Silico Prediction and Prioritization of Novel Selective Antimicrobial Drug Targets in Escherichia coli.

Authors:  Frida Svanberg Frisinger; Bimal Jana; Stefano Donadio; Luca Guardabassi
Journal:  Antibiotics (Basel)       Date:  2021-05-25

Review 10.  Modulation of Protein-Protein Interactions for the Development of Novel Therapeutics.

Authors:  Ioanna Petta; Sam Lievens; Claude Libert; Jan Tavernier; Karolien De Bosscher
Journal:  Mol Ther       Date:  2015-12-17       Impact factor: 11.454

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.